https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-05-29 / J Clin Oncol 38: 2020 (suppl; abstr e18022)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-05-29 / J Clin Oncol 38: 2020 (suppl; abstr e18022)2020-05-29 00:00:002020-05-29 00:00:00Dendritic cell vaccine as an alternative to opioid analgesia in patients with advanced cervical cancer.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-05-22 / Immunotargets Ther 2020;9:95-104
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-05-22 / Immunotargets Ther 2020;9:95-1042020-05-22 00:00:002020-05-22 00:00:00Dendritic Cell-Based Therapy Using LY6E Peptide with a Putative Role Against Colorectal Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-05-21 / Front Immunol 2020;11:924
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-05-21 / Front Immunol 2020;11:9242020-05-21 00:00:002020-05-21 00:00:00Dendritic Cells and Their Role in Immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-05-19 / Medicines (Basel) 2020 May;7(5)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-05-19 / Medicines (Basel) 2020 May;7(5)2020-05-19 00:00:002021-11-15 20:10:42Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-05-14 / Gene Ther. 2020 May;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-05-14 / Gene Ther. 2020 May;2020-05-14 00:00:002020-05-14 00:00:00Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-05-13 / Hum Vaccin Immunother 2020 May;:1-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-05-13 / Hum Vaccin Immunother 2020 May;:1-92020-05-13 00:00:002020-05-13 00:00:00Feasibility of dendritic cell-based vaccine against glioblastoma by using cytoplasmic transduction peptide (CTP)-fused protein antigens combined with anti-PD1
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-05-08 / J Therm Biol 2020 Jul;91:102615
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-05-08 / J Therm Biol 2020 Jul;91:1026152020-05-08 00:00:002020-05-08 00:00:00Hyperthermia and protein homeostasis: Cytoprotection and cell death
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-05-04 / Acta Pharmacol Sin 2020 Jul;41(7):959-969
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-05-04 / Acta Pharmacol Sin 2020 Jul;41(7):959-9692020-05-04 00:00:002023-03-13 09:01:09Ex vivo pulsed dendritic cell vaccination against cancer
